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ABSTRACT
This article estimates the magnitude and quality of antibiotic prescribing in Indonesian hospitals and
aims to identify demographic, socio-economic, disease-related and healthcare-related determinants of
use. An audit on antibiotic use of patients hospitalized for 5 days or more was conducted in two teaching
hospitals (A and B) in Java. Data were collected by review of records on the day of discharge. The method
was validated through concurrent data collection in Hospital A. Multivariate logistic regression analysis
was performed to determine variables to explain antibiotic prescribing. Prescriptions were assessed by
three reviewers using standardized criteria. A high proportion (84%) of 999 patients (499 in Hospital A
and 500 in Hospital B) received an antibiotic. Prescriptions could be categorized as therapeutic (53%) or
prophylactic (15%), but for 32% the indication was unclear. Aminopenicillins accounted for 54%, and
cephalosporins (mostly third generation) for 17%. The average level of antibiotic use amounted to
39 DDD ⁄ 100 patient-days. Validation revealed that 30% of the volume could be underestimated due to
incompleteness of the records. Predictors of antibiotic use were diagnosis of infection, stay in surgical or
paediatric departments, low-cost nursing care, and urban residence. Only 21% of prescriptions were
considered to be definitely appropriate; 15% were inappropriate regarding choice, dosage or duration,
and 42% of prescriptions, many for surgical prophylaxis and fever without diagnosis of infection, were
deemed to be unnecessary. Agreement among assessors was low (kappa coefficients 0.13–0.14). Despite
methodological limitations, recommendations could be made to address the need for improving
diagnosis, treatment and drug delivery processes in this setting.
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INTRODUCTION
Antimicrobial resistance is increasing worldwide,
in Gram-positive as well as Gram-negative bacte-
ria [1,2]. Antibiotic use contributes to the emer-
gence of antimicrobial resistance by selective
pressure [3]. In developing countries, antibiotics
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are prescribed for 44–97% of patients in hospital,
often unnecessarily or inappropriately [4–8]. Sev-
eral socio-economic and behavioural factors are
thought to contribute to the inappropriate use of
antibiotics and, consequently, to the increased
incidence of bacterial resistance in developing
countries [9]. In Indonesia, pathogens have be-
come resistant to many classes of antibiotics
[10,11]. There are no reliable data concerning the
quantity of antibiotic use and the appropriateness
of prescriptions in Indonesian hospitals.
In Indonesia, hospital care is delivered by
public and private providers. Public hospitals
include large governmental teaching hospitals
(Class A and Class B) and district hospitals. In
Class A hospitals, all medical (sub)specialties are
available. Public hospitals provide health services
to everyone at heavily subsidised prices. Health
insurance schemes are mandatory for government
employees and health subsidies are available for
the poor [12]. However, up to 86% of the
population is not covered by any form of health
insurance [12], and drugs for inpatients must be
purchased from a (hospital) pharmacy and paid
for in cash. The need to pay in cash also applies to
all laboratory investigations.
The Antimicrobial Resistance in Indonesia:
‘Prevalence and Prevention’ (AMRIN) study was
aimed at investigating antibiotic use and antimi-
crobial resistance inside and outside hospitals on
the island of Java, Indonesia. Recent antibiotic use
was the most important determinant of carriage
of resistant Escherichia coli in the study population
screened upon discharge from hospital [13], and
high rates of resistance to ampicillin (73%),
trimethoprim–sulphamethoxazole (56%) chl-
oramphenicol (43%) and ciprofloxacin (22%)
were found among these E. coli isolates [14]. In
this article, we describe the magnitude and
quality of antibiotic use of this patient group
and we explore the contribution of demographic,
socio-economic, healthcare-related and disease-
related variables to antimicrobial prescribing. We
hypothesized that, as well as being driven by
diagnosis of infection, antibiotic consumption
could also be determined by these variables.
PATIENTS AND METHODS
Population and healthcare setting
The study was performed in two Class A governmental
teaching hospitals. Dr Soetomo University Hospital in
Surabaya (Hospital A, 1432 beds) and Dr Kariadi University
Hospital in Semarang (Hospital B, 900 beds) report c. 60 000
and 26 000 admissions per year, respectively. Patients who
were hospitalized in the departments of internal medicine,
surgery, obstetrics and gynaecology (O&G) and paediatrics for
5 days or more were eligible for inclusion in the study on the
day of discharge. Only general wards of medicine and surgery
were included; specialized units (predominantly present in
Hospital A), renal units and intensive care units were
excluded. Patients were hospitalized in three different nursing
classes ranging from I to III, class I being the most expensive. In
nursing class I, patients were in a single room and antibiotics
were prescribed by a senior doctor. In nursing class II, patients
were in two-bed rooms, and in class III, 25–30 patients were
hospitalized in a 25–30-bed ward; the treating physician was a
resident under senior supervision. In Hospital A, antibiotic
policy guidelines and protocols had been developed in 1992,
but they had not been updated. In Hospital B, no documents
concerning antibiotic policy were available.
Study design and inclusion procedure
Written informed consent was obtained from all participants
and caretakers of children before enrolment. The medical
ethics committees of the hospitals approved of the study
protocol (ethical clearance Nos. Panke.KKE ⁄ 2001 (Surabaya)
and 11 ⁄EC ⁄ FK ⁄RSDK ⁄ 2001 (Semarang)). The patient selection
procedure is shown in Fig. 1. Patients were selected on three
fixed study days per week with a maximum of four patients
per day per department. Inclusion was discontinued when the
predetermined number of 125 patients per department was
reached. When more than four patients were discharged on
one study day, the patients with the longest duration of stay
were selected. Inclusion started at 8 a.m.
Data collection
On the day of discharge, data from the medical and nursing
records were noted in case report forms in both hospitals by
the same team of physicians and a number of trained data
collectors (medical students or junior physicians). The patients,
or caretakers of children, were interviewed to obtain data on
demographic and socio-economic variables. Data on antibiotic
use were extracted from medical records. Data on prescrip-
tions (type of antibiotic, dose, frequency, duration) were
obtained from the physician’s notes. Data on consumption
were obtained from the nurses’ notes in the same (standard
format) record. Medication charts with the actual record of
each dose were not available. Antibiotic consumption was
defined as the actual times and number of days that the
prescribed antibiotic was recorded as shown in these nursing
records. Patients, physicians or nurses were not approached
when information was missing.
Antimicrobial drug use was expressed as a percentage of
patients with at least one administered dose and as defined
daily doses (DDD) ⁄ 100 patient-days. The latter was calculated
from the consumption data using the Anatomical Therapeutic
Chemical classification index from the WHO Collaborating
Centre for Drugs Statistics Methodology 2003 (http://
www.whocc.no/atcddd/; accessed 15 July 2006). We used
the term ‘prescription’ to indicate each time an antibiotic was
prescribed. Modifications in type of antibiotic, dose or route
were considered to be new prescriptions [15].
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Validation of the quantitative data
The retrospective data collection was validated through
concurrent data collection in Hospital A. Thus, a random
sample of c. 40 patients was selected (ten in each depart-
ment for whom antibiotics had been prescribed on the day
of admission). An experienced pharmacist interviewed the
patients and nurses to gain information concerning
antibiotic use on the previous day. The pharmacist also
checked the nurse’s ‘injection book’, which was not part of
the medical and nursing records, but did contain data on
antibiotic administration. In cases of discrepancies
between the patients’ and nurses’ interviews, the pharma-
cist made the final decision after obtaining consensus
between the patient and nurse. In order to make blind
comparisons, the medical and nursing records were not
checked by the pharmacists. The nurses were not informed
of the reason for the validation, and, to avoid influencing
prescription behaviour, the treating physicians were not
approached by the pharmacist. These data on antibiotic use
were compared with the data extracted from the medical
records on the day of discharge by the researchers. In total,
100 fully documented patient-days per department were
compared.
Variables
Demographic variables included hospital, sex, age (over
18 years of age or 17 years and younger), living area (urban
or rural) and ethnicity. Socio-economic variables included
monthly family income level (below or above poverty line)
[16], employment (paid work for an employer on a regular
Inclusion procedure
by the AMRIN study team
Hospital A
July – October 2001
Departments Med, Surg,
Ob/Gyn, Paed discharged
n = 2283 
Hospital B
January – April 2002
Departments Med, Surg,
Ob/Gyn, Paed discharged
n = 2663 
Excluded
LOS < 5d
n = 1424
Excluded
LOS < 5d
n = 1565 
Included
125 patients/department
n = 500  
Included
125 patients/department
n = 500 (58%)
AMRIN inpatient
study population
Hospital B 
Excluded
n = 1
protocol violation
n = 499 (45%)
AMRIN inpatient
study population
Hospital A
Fig. 1. Study design of the Antimicrobial Resistance in Indonesia: ‘Prevalence and Prevention’ (AMRIN) study. Med,
medicine; Surg, surgery; Ob ⁄Gyn, obstetrics and gynaecology; Paed, paediatrics; LOS, length of stay.
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basis or having a regular income from a profession, e.g. farmer;
housewives and students were not considered to be unem-
ployed), education (primary school not completed vs. primary
school education and higher), and health insurance. Depart-
ment and nursing class were regarded as healthcare-related
variables and diagnosis of infection was chosen as the disease-
related variable.
Quality evaluation
The quality of antibiotic use was assessed according to the
method of Gyssens et al. [15]. Twenty records of patients who
used antibiotics were randomly selected from the 125 records
of each department, totalling 160 records. Abstracts for review
were made using the clinical information from the records.
Prescriptions were considered therapeutic if (a) the medical
record contained information that the antibiotic was pre-
scribed for therapy, or (b) an infectious disease was diagnosed,
or (c) clinical signs of infection, e.g. fever, were present on the
day that antibiotic therapy was started. Antibiotics were
classified as prophylactic if (a) the medical record stated that
the antibiotic was prescribed for prophylaxis or (b) the
antibiotic was given for only 1 day relative to the timing of a
surgical intervention. In all other cases, prescriptions were
termed as being of unknown indication.
Three clinicians, one from the relevant department, one
from another department of the same hospital and one foreign
expert on infectious diseases, independently reviewed every
abstract form. The Indonesian reviewers were chosen on the
basis of seniority and not on the basis of experience in
antimicrobial therapy, as these experts were not available. The
foreign expert had extensive experience with the evaluation
method [17,18]. The Indonesian reviewers were trained by one
of the Dutch investigators (ICG) during a 2-day course. Every
prescription was evaluated with the help of a flow chart, and
prescriptions were categorized as follows: definitely appropri-
ate; not indicated; inappropriate regarding dose, interval or
route; inappropriate regarding duration; inappropriate with
respect to efficacy, toxicity, broadness of spectrum or costs;
and insufficient information [15]. The assessments of the
individual reviewers were summarized in a combined evalu-
ation when at least two of the three reviewers evaluated the
prescription as appropriate, not indicated or inappropriate.
All other cases were classified as ‘no agreement among
reviewers’.
Statistical analysis
Individuals with experience of antibiotic use were compared
to individuals without experience of antibiotic use. Propor-
tions were compared among groups using the standard chi-
square test using a p value of <0.05 as the level of significance.
Univariate analysis was performed to determine the risk-
factors for antibiotic use. Variables for which the p value was
<0.05 in the univariate analysis were forced in a multivariate
model. Forward stepwise logistic regression was used. ORs,
significance and 95% CIs were calculated. SPSS for Windows
version 11.5 was used for all analyses.
With regard to the quality evaluation, agreement between
reviewers (pairwise) was assessed using Cohen kappa coeffi-
cients, which assume the value of 0 if there is only agreement
by chance, and a value of 1 for perfect agreement.
RESULTS
During the two study periods, 4946 patients
were discharged, of whom 1957 (40%) had been
hospitalized for 5 days or more. Among these
1957 patients, 999 (51%) were included (Fig. 1).
One patient from the O&G department in
Hospital A was included twice. The demo-
graphic characteristics are shown in Table 1.
No major differences were found except for the
variables living area and health insurance (both
p <0.001). Overall, almost three-quarters of the
patients had no health insurance. Over 40% of
patients who were 18 years or older were
unemployed, while over 90% of them had an
education level of at least primary school. One-
third of the population was younger than
18 years, reflecting the typical age distribution
of inpatients in a developing country. The
majority of patients were hospitalized in nurs-
ing class III facilities. In Hospital A, the inclu-
sion of 3% of nursing class I patients matched
the usual proportion of patients in this class. In
Table 1. Demographic characteristics of included patients in Hospitals A and B
Hospital A Hospital B Total p value
Total 499 500 999 (100)
Male 212 (43) 222 (44) 434 (43) 0.57
Age in years, median (range) 27 (0–81) 26 (0–88) 26 (0–88) 0.34
Adults ‡18 years old 334 (67) 337 (67) 671 (67) 0.89
Urban area 370 (74) 262 (52) 632 (63) 0.00
Javanese ethnicity 450 (90) 488 (97) 938 (94) 0.00
Low income 246 (49) 213 (43) 459 (46) 0.04
Unemployed, ‡18 years 145 (43) 138 (41) 283 (42) 0.53
Without education, ‡18 years 24 (7) 34 (10) 58 (8) 0.22
Without health insurance 385 (77) 317 (63) 702 (70) 0.00
Nursing class 0.01a
Class I 14 (3) 0 (0) 14 (1.4)
Class II 75 (15) 125 (25) 200 (20)
Class III 410 (82) 375 (75) 785 (79)
Length of stay in days, median (range) 9 (5–162) 8 (5–99) 9 (5–162) 0.67
aNursing classes I and II combined.
Values are given as n (%).
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Hospital B, inclusion of nursing class I patients
was not allowed. The mean (11.8 vs. 8.3 days)
and median (9 vs. 6 days) duration of stay of
included patients was higher than that of non-
included patients, indicating that the consump-
tion data primarily reflected antibiotic use in
patients with prolonged hospital stay.
Diagnoses on discharge
The most frequent diagnosis upon discharge
was infection; 278 cases (28%). In Hospital A,
the number of infections was double that in
Hospital B (193 vs. 85, p <0.001). The most
common infections were gastroenteritis with
diarrhoea (43 cases) and pneumonia (39 cases).
Significant differences were noted in the diag-
noses of dengue fever (14 in Hospital A and 23
in Hospital B, p 0.09), and typhoid fever (21 in
Hospital A and four in Hospital B, p 0.00). The
diagnosis of infection was mostly based on
clinical symptoms, as only minimal laboratory
investigations were performed. Other frequent
indications for admission were delivery (17%)
and malignancy (14% in Hospital A and 9% in
Hospital B).
Quantitative antibiotic use
An antibiotic was given to 834 of 999 (84%)
patients hospitalized for 5 days or more. In the
departments of surgery and paediatrics, almost
all patients staying for 5 days or more used
antibiotics (90%), while in the O&G and internal
medicine wards, respectively, 87% and 67% of
patients used antibiotics. Fifty-three per cent of
2058 prescriptions were categorised as therapy,
15% as prophylaxis and 32% as unknown indi-
cation. Overall, antibiotic use was 39 DDD ⁄ 100
patient-days, and it was 50% higher in Hospi-
tal A than in Hospital B (Table 2).
Sixty-two per cent of antibiotics were adminis-
tered intravenously. Penicillins (primarily ampi-
cillin and amoxicillin) accounted for 54% of the
total volume expressed in DDD ⁄ 100 patient-days.
The highest use of penicillins, 64.3 DDD ⁄ 100
patient-days, was found in the O&G department.
Cephalosporins were ranked second, comprising
17% of the total amount prescribed, 94% of which
was administered intravenously. The most
frequently prescribed cephalosporin was cefotax-
ime, followed by ceftriaxone. All but 20 of 487 of
cephalosporins prescribed belonged to the third
generation; four were first-generation, nine were
second-generation and seven were fourth-gener-
ation. Most cephalosporins were administered in
the department of surgery; 16.4 DDD ⁄ 100 patient-
days. Quinolones (ciprofloxacin) were ranked
third; 85% was administered orally. This class
was mostly used in the department of internal
medicine; 16.6 DDD ⁄ 100 patient-days. The mean
prescribed daily dose of most antibiotics was in
the order of magnitude of the DDD. For
cephalosporins and amphenicols, the prescribed
daily dose was c. 50% of the DDD.
Validation of the quantitative data
The results of the validation study showed
important differences between the retrospective
data from the nursing record and the concurrent
daily data collected by the pharmacist. The
Table 2. In-hospital consumption of antibiotics of patients discharged from Hospitals A and B
Antibiotic
(ATC code)
Hospital A Hospital B Total
Number of
patients
Number of
prescriptions
DDD ⁄ 100
patient-days (%)
Number of
patients
Number of
prescriptions
DDD ⁄ 100
patient-days (%)
Number of
patients
Number of
prescriptions
DDD ⁄ 100
patient-days (%)
Amphenicols (J01BA) 18 25 0.79 (2) 49 62 1.27 (4) 67 87 1.03 (2)
b-Lactam antibacterials,
penicillins (J01C)
278 490 25.86 (55) 277 470 16.14 (52) 555 960 21.05 (54)
Cephalosporins and related
substances (J01DA)
143 199 8.16 (17) 179 288 5.32 (17) 322 487 6.75 (17)
Trimethoprim–sulphameth
oxazole (J01EE01)
26 26 0.55 (1) 30 30 0.25 (1) 56 56 0.40 (1)
Aminoglycosides (J01G) 62 71 2.13 (5) 85 91 2.53 (8) 147 162 2.33 (6)
Quinolones (J01MA) 41 44 3.96 (8) 89 93 2.73 (9) 130 137 3.35 (9)
Metronidazole (J01XD01) 47 58 4.43 (9) 47 53 2.18 (7) 94 111 3.32 (9)
Other antibiotics 26 49 1.36 (3) 8 9 0.41 (1) 34 58 0.89 (2)
Total antibiotics 962 47.24 1096 30.83 2058 39.02
Other antibiotics included: tetracyclines, macrolides and lincosamides, meropenem, and fosfomycin.
ATC, Anatomical Therapeutic Chemical; DDD, defined daily doses.
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collection by the pharmacist yielded 1101 doses,
whereas only 775 administered doses were
retrieved from the nursing records of the same
calendar days for these patients. Three hundred
and eighty-three (35%) doses were not written in
the record, and 57 of 775 (7%) doses prescribed in
the physician’s notes of the medical records were
reported by patients as not taken or by nurses as
not administered. Thirty-eight (67%) of these
doses were metronidazole, cefotaxime, ceftriax-
one, ciprofloxacin or clindamycin, i.e. the more
costly or less commonly prescribed antibiotics.
Overall, the retrospective record review upon
discharge revealed an underestimation of 326
antibiotic doses, indicating that the actual antibi-
otic use by the patients was probably about 30%
higher.
Determinants of antibiotic use
Multivariate analysis of possible determinants for
antibiotic use in hospitalized patients identified
four independent variables (Table 3). The most
important determinant for antibiotic use was the
department from which the patient was dis-
charged. The likelihood of receiving an antibiotic
while hospitalised in the departments of surgery,
O&G or paediatrics was four to five times that in
the department of internal medicine. Having
an infection was the second most important
determinant of antibiotic use. Variables that
independently determined antibiotic use were
living in an urban area and being nursed in a
class III bed facility.
Quality of antibiotic prescriptions
Overall, 160 medical records containing 1153
antibiotic prescriptions were reviewed (Table 4).
In only 2% of cases did two or more reviewers
state that the medical record did not provide
enough information for an assessment of the
(non-) indication or inappropriateness of antibi-
otics. Approximately 60% of prescriptions were
classified as incorrect, either unjustified (not
indicated) or inappropriate, by at least two of
the three reviewers. Combined assessment
resulted in 21% of definitely appropriate
prescriptions, 28% in Hospital A and 16% in
Hospital B (p <0.001). Fifteen per cent of the
prescriptions were classified as inappropriate
regarding choice, dosage or duration of therapy.
Most importantly, 34% of prescriptions in
Hospital A and 48% in Hospital B were judged
to be not indicated (p <0.001). Antibiotic prophy-
laxis was administered unnecessarily for clean
surgery. Antibiotics were started days before the
operation and continued orally for several days
post-operatively (categorized as ‘for unknown
indication’ according to the study definition).
Antibiotic therapy was often initiated for ‘sepsis’
in the absence of objective clinical diagnostic
criteria or documented microbiological evidence
(culture report) of infection. Although the Indo-
nesian reviewers allocated approximately the
Table 3. Determinants of antibiotic use in patients
discharged from Hospitals A and B
Antibiotic
Yes
n = 834
Antibiotic
No
n = 165 OR (95% CI)
n (%) n (%) Univariate Multivariate
Hospital A 412 (49) 87 (53) 0.88 (0.63–1.22) NS
Male 365 (44) 69 (42) 1.08 (0.77–1.52) NS
Adult 547 (66) 124 (75) 0.63 (0.43–0.92) NS
Urban residence 542 (65) 90 (55) 1.55 (1.09–2.20) 1.86 (1.29–2.67)
Javanese ethnicity 780 (94) 158 (96) 0.64 (0.29–1.43) NS
Low income 378 (45) 81 (49) 0.86 (0.62–1.20) NS
Unemployed, ‡18 years 237 (43) 78 (37) 1.30 (0.85–1.98)
Primary school not
completed, ‡18 years
48 (9) 10(8) 1.10 (0.52–2.39)
No insurance 594 (71) 108 (66) 1.31 (0.92–1.86) NS
Nursing class
Class III 665 (80) 120 (73) Reference Reference
Class I + II 169 (20) 45 (27) 0.68 (0.46–0.99) 0.64 (0.43–0.96)
Department
Internal medicine 168 (20) 82 (50) Reference Reference
Surgery 224 (27) 26 (16) 4.21 (2.59–6.83) 4.87 (2.95–8.04)
Obstetrics ⁄ gynaecology 217 (26) 32 (19) 3.31 (2.10–5.22) 3.41 (2.15–5.41)
Paediatrics 225 (27) 25 (15.2) 4.39 (2.69–7.17) 4.47 (2.73–7.34)
Diagnosis
No infection 592 (71) 129 (78) Reference Reference
Infection 242 (29) 36 (22) 1.47 (0.98–2.18) 2.53 (1.58–4.07)
NS, not significant, adult ‡18 years old.
Table 4. Combined quality assessment of antibiotic pre-
scriptions (n = 1153) by three reviewers
Department
Definitely
appropriate Inappropriate
Unjustified,
no
indication
No
agreement
among
reviewers
Hospital A
Internal medicine 49 (46) 7 (7) 20 (19) 30 (28)
Paediatrics 33 (24) 48 (35) 25 (18) 33 (24)
Obstetrics ⁄
gynaecology
27 (25) 13 (12) 53 (49) 16 (14)
Surgery 38 (22) 22 (13) 80 (47) 31 (18)
Subtotal Hospital A 147 (28) 90 (17) 178 (34) 110 (21)
Hospital B
Internal medicine 25 (17) 20 (13) 71 (47) 35 (23)
Paediatrics 34 (22) 17 (11) 73 (47) 32 (21)
Obstetrics ⁄
gynaecology
13 (10) 14 (11) 71 (56) 28 (22)
Surgery 26 (13) 27 (14) 88 (45) 54 (28)
Subtotal Hospital B 98 (16) 78 (12) 303 (48) 149 (24)
Total 245 (21) 168 (15) 481 (42) 259 (22)
Values are given as n (%).
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same number of prescriptions in the various
assessment categories (Fig. 2), mutual agreement
was low (kappa coefficient 0.13) because prescrip-
tions were allocated to different categories. The
foreign expert’s judgement differed strongly from
that of the Indonesian reviewers (kappa coeffi-
cients 0.13 and 0.14), particularly regarding the
classification of prescriptions as definitely appro-
priate (Category I) and not indicated (Cate-
gory V) (Fig. 2).
DISCUSSION
This audit in two Indonesian governmental
hospitals showed that a high proportion (84%)
of inpatients was treated with antibiotics. The
proportion of patients treated with antibiotics was
similar in both hospitals, despite the fact that in
Hospital A the number of patients diagnosed
with an infection was double that in Hospital B.
In surgical and paediatric wards, almost all
patients were using antibiotics during their stay.
As compared to reviews in teaching hospitals
reported in the literature, this figure is in the
very high range. Studies in low-income and
developing countries have reported that 44–97%
of admitted patients are treated with antibiotics
[4–8]. In general wards of Western hospitals,
21–30% of patients were given antibiotics [17]. In
a recent point-prevalence survey of five European
university hospitals, only 14–32% of patients
were given antibiotics [19]. In contrast to this
high proportion of patients treated with antibiot-
ics, a consumption of 39 DDD ⁄ 100 patient-days
was calculated. This is a very low figure as
compared to other studies that used this unit of
measurement in teaching hospitals in developing
[5,6] and Western [17,18] countries. There are
several explanations for this relatively low con-
sumption figure in the present study. A validation
study in Hospital A revealed that 30% of the
volume could be underestimated due to incom-
pleteness of nursing records. Unlike in Western
hospitals, there was no actual record of each dose
being administered on a medication chart.
Second, children comprised one-third of the study
population for which the consumption was cal-
culated in DDD. No specific DDD are available
for children. A third possible explanation is that
the dosages for cephalosporins and amphenicols
prescribed to adults were lower than the DDD
for these antibiotics. A fourth reason may be that,
in this study, the day of admission and the day of
discharge were both counted as days of exposure.
When the antibiotic use data are adjusted for the
inclusion of children, admission and discharge
days are counted as 1 day of exposure, and the
30% rate of underestimation is taken into account,
antibiotic consumption is 62 DDD ⁄ 100 patient-
days. Even after this correction, the volume of
antibiotic use in the Indonesian hospitals in this
study was low as compared to published data.
For example, in a Brazilian tertiary hospital,
antibiotic use was 84 DDD ⁄ 100 patient-days in
1990 and increased to 125 in 1996 [6]. In a teaching
hospital in Iran, antibiotic consumption
amounted to 102 DDD ⁄ 100 patient-days [5]. Con-
sumption was also lower than in a report from the
internal medicine department of a Dutch univer-
sity hospital, where antibiotic use increased from
60 to 73 DDD ⁄ 100 patient-days after an inter-
vention [18].
In this study, one important determinant of use,
besides the clinical diagnosis of infection, was
hospitalization in a surgical department, either
O&G or general surgery. In these departments,
many doses of oral aminopenicillins, given post-
0
100
200
300
400
500
600
700
800
Categories
N
um
be
r o
f p
re
sc
rip
tio
ns Reviewer 1
Reviewer 2
Reviewer 3
Cat-I Cat-V Cat-other Cat-VI
Fig. 2. Quality assessment of antimicrobial drug prescrip-
tions (n = 1153) by three reviewers. Reviewer 1 was a
senior physician from the relevant department, reviewer 2
was from another department, and reviewer 3 was an
infectious diseases expert from The Netherlands. Cat-I,
category I, definitely appropriate; Cat-V, category V,
unjustified, no indication; Cat-other, inappropriate for
several reasons; Cat-VI, unevaluable due to insufficient
information.
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operatively until discharge to patients without
signs of infection, were identified as unnecessary
prophylaxis in the quality evaluation. Another
healthcare-related variable, nursing class III, that
determined antibiotic use could also be inter-
preted as socio-economic (poor patient popula-
tion), although the socio-economic variables of
low income and lack of health insurance were not
independent determinants of antibiotic use in
hospital. Interestingly, nursing class was not a
significant indicator of hospital-acquired infection
in the same period in these hospitals [20]. This
finding may point to a difference in the prescrib-
ing behaviour of the junior physicians in charge of
the class III wards, as compared to that of senior
physicians in charge of class I rooms. The only
positive demographic determinant, living in an
urban area, may point towards a higher demand
for antibiotics on the part of patients who are city
dwellers. The choice of antibiotics in the two
hospitals was as strikingly similar as the high
proportion of patients treated with antibiotics.
Low-cost amoxycillin, ampicillin and ampheni-
cols accounted for more than half of the prescrip-
tions. In the absence of updated guidelines,
economic and other, unidentified determinants
of prescribing in developing countries, such as
fear of bad clinical outcomes and conformance
with peers [21], could be responsible for this
uniform prescribing behaviour.
The quality evaluation confirmed over-pre-
scription in surgical and O&G departments and
identified major room for improvement in surgi-
cal prophylaxis, which is a frequently encoun-
tered problem area in Western university
hospitals also [17–19], and identified major room
for improvement in surgical prophylaxis. Assess-
ment reports of antibiotic prescriptions in hospi-
tals in low-income or developing countries are
scarce. Two studies that assessed the quality of
prescribing in a teaching hospital in Thailand
reported 92% of prescriptions as being incorrect
in 1985 [22] and 26% of prescriptions as being
incorrect in 2000 [23]. As compared with reports
from a Dutch university hospital before an
intervention in 1992, the quality of antibiotic
prescribing in the two Indonesian hospitals was
not particularly low. Using the same audit
methodology, 15% of the prescriptions were
assessed as appropriate, 39% as unjustified and
46% as inappropriate at the baseline before an
intervention [17].
In this study, agreement among reviewers was
lower than in the studies in a Dutch university
hospital, in which the foreign expert was one of
the reviewers [17,18]. Disagreement with the
Indonesian reviewers was probably due to the
completely different frame of reference. Stein et al.
described similar assessor disagreements during
their survey in Zimbabwe, illustrating the diffi-
culties encountered when applying accepted
guidelines for antibiotic use to developing coun-
tries [24]. More puzzling was the strong disagree-
ment among the Indonesian reviewers. A possible
explanation is that, in the absence of specific
training in infectious diseases, they had no agreed
standards against which to judge prescribing
behaviour, and they had very different back-
grounds as surgeons, gynaecologists, paediatri-
cians or internists; also, local medical culture, e.g.
peer influence, may have played a role [21]. The
limited agreement among reviewers could prob-
ably be increased by longer and better training in
evidence-based clinical practice to improve exper-
tise, although this would not result in full agree-
ment [17]. Assessment of adherence to guidelines,
rather than reviewers’ opinions, does not guaran-
tee high kappa coefficients [25].
There are several limitations of this study. First,
the study was designed to concurrently detect
nasal and rectal carriage of resistant bacteria in
the study population [13]. This required the
inclusion of patients admitted for 5 days or more
prior to discharge. Therefore, the consumption
figures are not fully comparable with other
reports. Nevertheless, this information can be
considered very relevant, because the group of
long-stay patients was the most vulnerable, con-
sidering that antibiotic use is related to the
acquisition of multidrug-resistant bacteria and
their infectious consequences. Also, a possible
role of case-mix in explaining the striking differ-
ence in consumption between the current study
populations and those of Western countries
cannot be entirely excluded. Second, the data
collection concerning antibiotic use relied on
retrospective review of medical records on the
day of discharge. Although this method is com-
monly used in developing countries [4–8], the
level of use could not be measured accurately in
this study, due to the absence of accurate med-
ication charts and the poor quality of medication
record-keeping in the hospitals. The irregular and
delayed dispensing of antibiotics in the hospitals
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appeared to be influenced by the fact that most
hospitalized patients were obliged to pay cash for
the prescribed drugs at a (hospital) pharmacy,
rather than an unstable supply of drugs to the
healthcare facility. Concurrent review with daily
interviews, as during the validation, would ren-
der the collection more accurate, but was consid-
ered not to be feasible for 1000 patients. In
contrast, measurement of the proportion of
patients that received antibiotics, deduced from
physicians’ notes, was accurate. Similarly, the
clinical information from the medical records was
sufficient for quality assessment. In the Dutch
university hospital, up to 10% of prescriptions
could not be evaluated [17,18], mostly because of
the complexity of the cases. Third, the data were
collected during different seasons, resulting in a
different case-mix. However, the uniformity of
the data collection method, using the same
trained data collectors in both hospitals, is an
important asset of the study. Finally, the findings
cannot be generalized for Indonesia. Hospi-
tals A and B are probably representative of other
governmental teaching hospitals, but not of the
many private hospitals that deliver healthcare to a
wealthy proportion of the Indonesian population.
It is of note that, in Indonesia, senior physicians in
public hospitals can offer private services after
office hours and practise in both types of institu-
tion [12]. We cannot exclude the possibility that
antibiotic use in private hospitals differs substan-
tially from that in governmental hospitals due to
socio-economic and cultural factors.
In conclusion, the drug utilization method for
quantitative and qualitative assessment devel-
oped in Western hospitals may need to be adapted
for the Indonesian hospital setting. Some method-
ological issues could be resolved by conducting
concurrent point-prevalence measurements of
observed use and by employing more experienced
assessors. However, this audit revealed the need
for strong commitment on the part of the medical
community to major improvements in medical
diagnoses and medication record-keeping, in the
training of those who review the process of
prescribing, and in the clinical and diagnostic
practice guidelines for surgical prophylaxis and
sepsis. Feedback of results set the stage for
acceptance of recommendations for hospital-wide
practice and future interventions, including reor-
ganization of the drug distribution policy of
hospital pharmacies, introduction of appropriate
medication charts, and better use of microbiolog-
ical diagnostic facilities.
ACKNOWLEDGEMENTS
The data collectors, S. Werter, K. Cheung, E. B. Santoso, H.
Susatyo, A. Achyar, S. Wibisono, Bramantono, Yeni, Upik,
Irma, P. Hadi, Vera, R. de Jong and R. van der Meulen, are
gratefully acknowledged.
TRANSPARENCY DECLARATION
Financial support was provided by the Royal Netherlands
Academy of Arts and Sciences, within the framework of the
Scientific Programme Indonesia–Netherlands (SPIN 1). The
authors declare no conflict of interest in relation to this study.
REFERENCES
1. Beekmann SE, Heilmann KP, Richter SS. Antimicrobial
resistance in Streptococcus pneumoniae, Haemophilus influ-
enzae, Moraxella catarrhalis and group A beta-haemolytic
streptococci in 2002–2003. Int J Antimicrob Agents 2005; 25:
148–156.
2. Erb A, Stu¨rmer T, Brenner H. Prevalence of antibiotic
resistance in Escherichia coli: overview of geographical,
temporal, and methodological variations. Eur J Clin
Microbiol Infect Dis 2007; 26: 83–90.
3. Bronzwaer SLAM, Cars O, Buchholz U et al. A European
study on the relationship between antimicrobial use and
antimicrobial resistance. Emerg Infect Dis 2002; 8:
278–282.
4. Orrett FA. Antimicrobial prescribing patterns at a rural
hospital in Trinidad: evidence for intervention measures.
Afr J Med Sci 2001; 30: 161–164.
5. Ansari F. Use of systemic anti-infective agents in Iran
during 1997–1998. Eur J Clin Pharmacol 2001; 57: 547–551.
6. De Castro MS, Pilger D, Ferreira MB, Kopittke L. Trends in
antimicrobial utilization in a university hospital, 1990–
1996. Rev Saude Publica 2002; 36: 553–558.
7. Chukwuani CM, Onifade M, Sumonu K. Survey of drug
practices and antibiotic prescribing at a general hospital in
Nigeria. Pharm World Sci 2002; 24: 188–195.
8. Hu S, Liu X, Peng Y. Assessment of antibiotic prescription
in hospitalized patients at a Chinese university hospital.
J Infect 2004; 48: 117–118.
9. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and
behavioral factors leading to acquired bacterial resistance
to antibiotics in developing countries. Emerg Infect Dis
1999; 5: 18–27.
10. Tjaniadi P, Lesmana M, Subekti D et al. Antimicrobial
resistance of bacterial pathogens associated with diarrheal
patients in Indonesia. Am J Trop Med Hyg 2003; 68:
666–670.
11. Ieven M, Van Looveren M, Sudigdoadi S et al. Antimi-
crobial susceptibilities of Neisseria gonorrhoeae strains
isolated in Java, Indonesia. Sex Transm Dis 2003; 30: 25–30.
12. Hidayat B, Thabrany H, Dong H, Sauerborn R. The effects
of mandatory health insurance on equity in access to
outpatient care in Indonesia. Health Policy Plan 2004; 19:
322–335.
706 Clinical Microbiology and Infection, Volume 14 Number 7, July 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 698–707
13. Duerink DO, Lestari ES, Hadi U et al. Determinants of
carriage of resistant Escherichia coli in the Indonesian
population inside and outside hospitals. J Antimicrob
Chemother 2007; 60: 377–384.
14. Lestari ES, Severin JA, Filius PMG et al. Antimicrobial
resistance among commensal isolates of Escherichia coli and
Staphylococcus aureus in the Indonesian population inside
and outside hospitals. Eur J Clin Microbiol Infect Dis 2008;
27: 45–51.
15. Gyssens IC, Van den Broek PJ, Kullberg BJ, Hekster YA,
Van der Meer JWM. Optimizing antimicrobial therapy. A
method for antimicrobial drug evaluation. J Antimicrob
Chemother 1992; 30: 724–727.
16. BPS-Statistics Indonesia BAPPENAS and UNDP. The eco-
nomics of democracy. Financing human development in Indo-
nesia. Jakarta, Indonesia: BPS-Statistics Indonesia
BAPPENAS and UNDP, 2004.
17. Gyssens IC, Geerligs IEJ, Dony JMJ et al. Optimising
antimicrobial drug use in surgery: an intervention study in
a Dutch university hospital. J Antimicrob Chemother 1996;
38: 1001–1012.
18. Gyssens IC, Blok WL, Van den Broek PJ, Hekster YA, Van
der Meer JWM. Implementation of an educational pro-
gram and an antibiotic order form to optimize quality of
antimicrobial drug use in a department of internal medi-
cine. Eur J Clin Microbiol Infect Dis 1997; 16: 904–912.
19. Vlahovic-Palcevski V, Dumpis U, Mitt P et al. Bench-
marking antimicrobial drug use at university hospitals in
five European countries. Clin Microb Infect 2007; 13: 277–
283.
20. Duerink DO, Roeshadi D, Wahjono H et al. Surveillance of
healthcare-associated infections in Indonesian hospitals.
J Hosp Infect 2006; 62: 219–229.
21. Radyowijati A, Haak H. Improving antibiotic use in low-
income countries: an overview of evidence on determi-
nants. Soc Sci Med 2003; 57: 733–744.
22. Aswapokee N, Vaithayapichet S, Heller RF. Pattern of
antibiotic use in medical wards of a university hospital,
Bangkok, Thailand. Rev Infect Dis 1990; 12: 136–141.
23. Ayuthya SK, Matangkasombut OP, Sirinavin SM, Malat-
hum K, Sathapatayavongs B. Utilization of restricted
antibiotics in a university hospital in Thailand. Southeast
Asian J Trop Med Public Health 2003; 34: 179–186.
24. Stein CM, Todd WTA, Parirenyatwa D, Chakonda J,
Dizwani AGM. A survey of antibiotic use in Harare
primary care clinics. J Antimicrob Chemother 1984; 14:
149–156.
25. Mol PGM, Wierenga JE, NannanPanday PV et al.
Improving compliance with hospital antibiotic guidelines:
a time-series intervention analysis. J Antimicrob Chemother
2005; 55: 550–557.
A P P E N D I X
Dr Soetomo Hospital – School of Medicine
Airlangga University Surabaya, Indonesia:
W. Gardjito; E. P. Kolopaking; K. Wirjoatmodjo;
D. Roeshadi; E. Suwandojo; H. Parathon; U. Hadi;
N. Zairina; E. Isbandiati; K. Deborah; K. Kunt-
aman; N. M. Mertaniasih; M. Purwanta.
Dr Kariadi Hospital – School of Medicine
Diponegoro University Semarang, Indonesia:
A. Soejoenoes; B. Riyanto; H. Wahjono;
M. Adhisaputro; B. Triwara; J. Syoeib; E. S.
Lestari; B. Wibowo; M. A. U. Sofro; H. Farida;
M.M.D.E.A.H. Hapsari; T. L. Nugraha.
Leiden University Medical Centre, Leiden,
The Netherlands:
P. J. van den Broek; D. O. Duerink.
Erasmus University Medical Centre,
Rotterdam, The Netherlands:
H. A. Verbrugh; I. C. Gyssens.
Radboud University Medical Centre,
Nijmegen, The Netherlands:
M. Keuter.
Hadi et al. Antibiotic prescribing in public hospitals in Indonesia 707
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 698–707
